Latest New Zealand News

PaySauce has moved its Global Payroll Platform from development into commercial operation in Australia, while first-quarter FY27 ARR rose 8% to $9.5 million. The expansion is supported by a stronger cash position, but higher customer acquisition costs and lower profitability leave execution firmly in focus.

Bathurst Resources must provide further information before its fast-track application for the Buller Plateaux Continuation Project can proceed. The two outstanding issues concern a wildlife approval and consent from a reserve manager.

RocketBoots has completed a successful trial with a major Mexican retail bank operating more than 1,200 branches, opening discussions over a possible wider rollout. The company also renewed a 12-month agreement with a long-standing New Zealand banking customer, with total invoices raised of approximately A$231,000.

4DMedical delivered sharp growth in scans, sites and operating revenue as CT:VQ moved into commercial deployment across several global markets. But the company remains loss-making and its auditor issued a qualified opinion over the carrying value of goodwill and other intangible assets.

The ACCC has determined that I Squared Capital's proposed acquisition of oOh!media may proceed by scheme of arrangement, removing a major regulatory condition. Approval from Australia's FIRB, New Zealand's OIO and oOh!'s shareholders is still required before completion.

Zimi has secured an exclusive three-year distribution agreement with Directed for retail, direct-to-consumer and direct-to-business sales across Australia and New Zealand. The deal gives its next-generation Matter devices access to more than 10,000 retail outlets, although commercial terms and guaranteed sales volumes remain undisclosed.

PainChek grew recurring revenue, implemented licences and customer sites in FY2026, but its $8.94 million loss and $9.24 million operating cash outflow prompted an explicit going-concern warning from its auditor. The company is now betting that US deployments and a sharper commercial focus can convert market access into cash-generating growth.

Minerals Exploration has intersected broad, lower-grade gold mineralisation with higher-grade structures in four holes at Jubilee South, expanding the interpreted system toward Sovereign. The company is preparing a six-hole, 1,200-metre Sovereign program, subject to approvals, while caution remains around recovery and unproven continuity.

MyEco Group is seeking up to $1.5 million through a discounted, non-underwritten share purchase plan to expand council and waste management sales, retail distribution and its eco-home range. The final issue price and amount raised remain uncertain, with the company retaining the option to scale up the offer or pursue a follow-on placement.

CAR Group has confirmed a DRP price of AUD 23.651 for its 43.5-cent ordinary dividend, payable on 12 October. The distribution is 30% franked and will be issued at no discount to participating shareholders.

Booster Innovation Fund has invested $200,000 in TheiaNova, a University of Auckland spinout developing a self-administered eye drop for keratoconus. The seed-stage bet accounts for 0.76% of BIF’s portfolio, keeping the exposure modest while adding an early biotechnology asset.

Rua Bioscience delivered a sharp rise in customer revenue and secured a UK agreement expected to generate NZ$10 million over two years. But PwC disclaimed an audit opinion, warning the company may not have enough cash without another capital raise.